| Net loss | -99.57K |
| Depreciation and amortization | |
| Stock-based compensation | |
| Amortization of deferred loan issuance costs | 17.07K |
| (Gain) loss on sale/settlement of assets | |
| Deferred income tax benefit | -47.99K |
| Receivables and other assets | -1.18M |
| Accounts payable and accrued liabilities | -1.4M |
| Net cash provided by (used in) operating activities | |
| Capitalized development costs | |
| Purchase of property and equipment | -655.12K |
| Proceeds from the sale of assets | 0 |
| Net (additions) and reductions of restricted cash | |
| Net cash provided by (used in) investing activities | |
| Payments on capital lease | 0 |
| Employee stock plan purchases | 13.04K |
| Proceeds from (repayment of) short term loans | |
| Net cash provided by (used in) financing activities | |
| Net increase (decrease) in cash and cash equivalents | -2.76M |
| Cash and cash equivalents at beginning of period | 11.58M |
| Cash and cash equivalents at end of period | 8.83M |
| Cash paid for interest | 184.53K |
| Non-cash purchase of property and equipment | |